期刊文献+

坎地沙坦酯自微乳软胶囊的制备

Preparation of Candesartan Cilexetile self-microemulsifying soft capsules
下载PDF
导出
摘要 目的通过坎地沙坦酯自微乳软胶囊的制备工艺研究,确定其最佳工艺条件。方法采用伪三元相图优化了软胶囊内容物的配方,并制备和优化了载药自微乳软胶囊的工艺。结果内容物以乙酸乙酯为油相,RH40为乳化剂,聚乙二醇400为助乳化剂,且三者最佳配比为9∶14∶7。软胶囊囊壳材料最佳配比为明胶∶甘油∶水=1∶0.5∶1,且评价了坎地沙坦酯自微乳软胶囊的相关特性。结论本工艺简单、稳定、可靠。 OBJECTIVE To investigate the optimal technology of preparation technique of candesartan cilexetile self-microemulsifying soft capsules. METHODS Pseudoternary phase diagrams were used to optimize the formulation of content of soft capsules. The technology of drug-loaded self-microemulsifying soft capsules were prepared and optimized. RESULTS The content of soft capsules were made of acetic ether (as oil), RH40 (as emulsifier), PEG400 (as co-emulsifier). The best ratio of three things was acetic ether RH40:PEG400 = 9:14: 7. And the best ratio of soft capsules crust is gelatin: glycerin., water = 1 : 0.5 : 1. The correlative characteristic of candesartan cilexetile self-microemulsifying soft capsules were evaluated.CONCLUSION This preparation method is simple, stable and reliable.
出处 《海峡药学》 2012年第5期11-13,共3页 Strait Pharmaceutical Journal
基金 武汉市科技局攻关项目(编号:200960323126)
关键词 坎地沙坦酯自微乳软胶囊 制备工艺 质量评价 Candesartan cilexetile self-microemulsifying soft capsule Technology of preparation technique Evaluation of quality
  • 相关文献

参考文献6

二级参考文献30

  • 1肖连生,郑楠,高鸿雁,周欣.聚乙二醇400在口服软胶囊剂中的应用研究[J].天津药学,1996,8(3):33-34. 被引量:21
  • 2蔡德山.浅谈沙坦类抗高血压新药市场[J].中国制药信息,2007,23(4):29-32. 被引量:2
  • 3初代秀一 长腾升 丰田智淳 等.改进了服用性的咀嚼型软胶囊剂及其制法[P].CN:1348364.2002-05-08.
  • 4Johnston CL. Angiotensin receptor antagonists: focus on losartan [J]. Lancet,2000,346(8987):1403-1407.
  • 5Gleiter CH,Jagle C, Gresser U, et al. Candesartan Cardiovasc[J ] Drug Rev,2004,22(4):263-284.
  • 6Gleiter CH, Morike KE. Clinical pharmacokinetics of candesartan [J ]. Clinical Pharmacokinetics, 2002,41 ( 1 ) : 7 - 17.
  • 7Oparil S, Levine JH, Zuschke CA, et al. Effects of candesartan cilexetil in patients with severe systemic hypertension. Candesartan Cilexetil Study Investigators[J]. Am J Cardiol, 1999,84(3) :289 - 293.
  • 8Me Kelvie RS,Rouleau J, Latini R, et al. Comparison of candesartun, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigatotrs[J ]. Circulation, 1999,100(10) : 1056 - 1064.
  • 9Mitrovic V, Willenbrock R, Miric M, et al. Acute and 3-month treatment effects of candesartan cilexetil on hemodynamics, neurohormones, and clinical symptoms in patients with congestive heart failure[J]. Am Heart J ,2003,145(3) :E14.
  • 10Baguet JP,Barone-Rochette G, Neuder Y. Candesartan cilexetil in the treatment of chronic heart failure[J]. Vasc Health Risk Manag,2009,5(1):257-264.

共引文献79

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部